Piroxicam and Cisplatin Show Promise Against Mesothelioma Cells
Piroxicam, a nonsteroidal anti-inflammatory drug (NSAID), has shown anti-tumoral activity which is amplified when combined with Cisplatin. Researchers used two mesothelioma cell lines and treated cells with piroxicam and cisplatin alone then combined the two treatments. Cell growth was significantly limited in both lines and treatment with either agent appeared to disrupt cell cycle phase […]
Piroxicam and Cisplatin Show Promise Against Mesothelioma Cells Read More »